Feasibility and efficacy of moderate-intensity stereotactic body radiotherapy for ultracentral lung cancer
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0006736
- Lead Sponsor
- Korea University Ansan Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
patients having ultracentral lung tumor treated with stereotactic body radiotherapy in Korea University Ansan Hospital
Exclusion Criteria
the patients having other malignancies than ultracentral lung tumor
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method local control, overall survival
- Secondary Outcome Measures
Name Time Method toxicity of grade 2 or higher